Xylem Inc Stock Probability Of Bankruptcy

XYL Stock

USD 126.75 1.14 0.91%

Xylem's odds of distress is less than 3% at the moment. It is unlikely to undergo any financial straits in the next 24 months. Xylem's Odds of financial distress is determined by interpolating and adjusting Xylem Altman Z Score to account for off-balance-sheet items and missing or unfiled public information. All items used in analyzing the odds of distress are taken from the Xylem balance sheet, as well as cash flow and income statements available from the company's most recent filings. Check out Xylem Piotroski F Score and Xylem Altman Z Score analysis.

Xylem Inc Company odds of financial distress Analysis

Xylem's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Probability Of Bankruptcy

Normalized

Z-Score

More About Probability Of Bankruptcy | All Equity Analysis

Current Xylem Probability Of Bankruptcy

Less than 3%

Most of Xylem's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Xylem Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Our calculation of Xylem probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Xylem odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Xylem Inc financial health.

Is Industrial Machinery & Supplies & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xylem. If investors know Xylem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xylem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.413

Dividend Share

1.41

Earnings Share

3.49

Revenue Per Share

34.788

Quarterly Revenue Growth

0.013

The market value of Xylem Inc is measured differently than its book value, which is the value of Xylem that is recorded on the company's balance sheet. Investors also form their own opinion of Xylem's value that differs from its market value or its book value, called intrinsic value, which is Xylem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xylem's market value can be influenced by many factors that don't directly affect Xylem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

	Total Assets	Total Stockholder Equity	Net Debt	Accounts Payable	Net Receivables	Good Will	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Property Plant Equipment	Net Tangible Assets	Current Deferred Revenue	Retained Earnings	Long Term Debt	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Treasury Stock	Short Term Debt	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.96	0.38	0.76	0.79	0.99	0.67	0.71	0.97	-0.34	0.68	0.01	-0.52	0.69	0.62	0.58	0.85	0.43	-0.7	0.02	-0.02	0.56	0.8	0.65	0.8
Total Stockholder Equity	0.96		0.17	0.63	0.72	0.98	0.45	0.57	0.92	-0.18	0.47	0.21	-0.37	0.52	0.4	0.36	0.75	0.25	-0.52	-0.1	-0.14	0.41	0.83	0.58	0.87
Net Debt	0.38	0.17		0.54	0.5	0.35	0.73	0.3	0.54	-0.56	0.82	-0.82	-0.57	0.53	0.72	0.72	0.44	0.85	-0.55	0.48	0.46	0.13	0.16	-0.03	0.12
Accounts Payable	0.76	0.63	0.54		0.95	0.7	0.87	0.86	0.75	-0.36	0.88	-0.22	-0.78	0.94	0.79	0.76	0.97	0.57	-0.83	0.15	0.12	0.62	0.77	0.65	0.66
Net Receivables	0.79	0.72	0.5	0.95		0.77	0.78	0.8	0.79	-0.39	0.81	-0.09	-0.68	0.82	0.63	0.59	0.93	0.47	-0.69	0.08	0.06	0.47	0.87	0.55	0.81
Good Will	0.99	0.98	0.35	0.7	0.77		0.57	0.6	0.98	-0.27	0.6	0.03	-0.46	0.59	0.53	0.49	0.79	0.4	-0.6	0.01	-0.03	0.44	0.81	0.56	0.84
Total Liab	0.67	0.45	0.73	0.87	0.78	0.57		0.87	0.69	-0.58	0.97	-0.46	-0.73	0.91	0.92	0.91	0.85	0.71	-0.85	0.3	0.26	0.73	0.56	0.6	0.41
Total Current Assets	0.71	0.57	0.3	0.86	0.8	0.6	0.87		0.62	-0.47	0.77	0.01	-0.61	0.88	0.71	0.69	0.9	0.35	-0.79	0.03	-0.01	0.86	0.71	0.84	0.56
Intangible Assets	0.97	0.92	0.54	0.75	0.79	0.98	0.69	0.62		-0.35	0.73	-0.17	-0.54	0.67	0.66	0.63	0.81	0.56	-0.68	0.13	0.09	0.46	0.76	0.52	0.77
Common Stock	-0.34	-0.18	-0.56	-0.36	-0.39	-0.27	-0.58	-0.47	-0.35		-0.58	0.11	0.32	-0.39	-0.31	-0.31	-0.35	-0.27	0.41	-0.14	-0.12	-0.19	-0.13	-0.15	-0.09
Property Plant Equipment	0.68	0.47	0.82	0.88	0.81	0.6	0.97	0.77	0.73	-0.58		-0.53	-0.78	0.88	0.91	0.9	0.82	0.79	-0.83	0.35	0.32	0.59	0.52	0.48	0.41
Net Tangible Assets	0.01	0.21	-0.82	-0.22	-0.09	0.03	-0.46	0.01	-0.17	0.11	-0.53		0.39	-0.26	-0.63	-0.66	-0.09	-0.78	0.3	-0.59	-0.59	-0.06	0.17	0.21	0.24
Current Deferred Revenue	-0.52	-0.37	-0.57	-0.78	-0.68	-0.46	-0.73	-0.61	-0.54	0.32	-0.78	0.39		-0.8	-0.74	-0.74	-0.71	-0.48	0.76	-0.47	-0.47	-0.46	-0.38	-0.37	-0.28
Retained Earnings	0.69	0.52	0.53	0.94	0.82	0.59	0.91	0.88	0.67	-0.39	0.88	-0.26	-0.8		0.84	0.83	0.94	0.6	-0.95	0.13	0.1	0.73	0.6	0.67	0.46
Long Term Debt	0.62	0.4	0.72	0.79	0.63	0.53	0.92	0.71	0.66	-0.31	0.91	-0.63	-0.74	0.84		1.0	0.76	0.81	-0.84	0.42	0.39	0.72	0.43	0.58	0.3
Long Term Debt Total	0.58	0.36	0.72	0.76	0.59	0.49	0.91	0.69	0.63	-0.31	0.9	-0.66	-0.74	0.83	1.0		0.73	0.82	-0.83	0.43	0.41	0.72	0.38	0.56	0.24
Capital Surpluse	0.85	0.75	0.44	0.97	0.93	0.79	0.85	0.9	0.81	-0.35	0.82	-0.09	-0.71	0.94	0.76	0.73		0.5	-0.88	0.07	0.03	0.68	0.82	0.74	0.73
Deferred Long Term Liab	0.43	0.25	0.85	0.57	0.47	0.4	0.71	0.35	0.56	-0.27	0.79	-0.78	-0.48	0.6	0.81	0.82	0.5		-0.59	0.26	0.24	0.31	0.21	0.19	0.14
Treasury Stock	-0.7	-0.52	-0.55	-0.83	-0.69	-0.6	-0.85	-0.79	-0.68	0.41	-0.83	0.3	0.76	-0.95	-0.84	-0.83	-0.88	-0.59		-0.19	-0.15	-0.69	-0.47	-0.63	-0.35
Short Term Debt	0.02	-0.1	0.48	0.15	0.08	0.01	0.3	0.03	0.13	-0.14	0.35	-0.59	-0.47	0.13	0.42	0.43	0.07	0.26	-0.19		1.0	0.04	-0.1	-0.1	-0.11
Short Long Term Debt	-0.02	-0.14	0.46	0.12	0.06	-0.03	0.26	-0.01	0.09	-0.12	0.32	-0.59	-0.47	0.1	0.39	0.41	0.03	0.24	-0.15	1.0		0.02	-0.14	-0.13	-0.15
Cash And Equivalents	0.56	0.41	0.13	0.62	0.47	0.44	0.73	0.86	0.46	-0.19	0.59	-0.06	-0.46	0.73	0.72	0.72	0.68	0.31	-0.69	0.04	0.02		0.47	0.87	0.29
Net Invested Capital	0.8	0.83	0.16	0.77	0.87	0.81	0.56	0.71	0.76	-0.13	0.52	0.17	-0.38	0.6	0.43	0.38	0.82	0.21	-0.47	-0.1	-0.14	0.47		0.63	0.97
Net Working Capital	0.65	0.58	-0.03	0.65	0.55	0.56	0.6	0.84	0.52	-0.15	0.48	0.21	-0.37	0.67	0.58	0.56	0.74	0.19	-0.63	-0.1	-0.13	0.87	0.63		0.51
Capital Stock	0.8	0.87	0.12	0.66	0.81	0.84	0.41	0.56	0.77	-0.09	0.41	0.24	-0.28	0.46	0.3	0.24	0.73	0.14	-0.35	-0.11	-0.15	0.29	0.97	0.51

	2019	2020	2021	2022	2023	2024 (projected)
Return On Assets	0.052	0.029	0.0516	0.0446	0.0378	0.065
Asset Turnover	0.69	0.72	0.68	0.56	0.63	0.46
Net Debt	1.6B	1.2B	1.1B	1.0B	1.4B	1.1B
Total Current Liabilities	1.5B	2.0B	1.4B	1.6B	2.2B	1.3B
Non Current Liabilities Total	3.2B	3.8B	3.7B	2.9B	3.7B	2.7B
Total Assets	7.7B	8.8B	8.3B	8.0B	16.1B	16.9B
Total Current Assets	2.5B	3.5B	3.2B	3.0B	3.9B	2.5B
Total Cash From Operating Activities	839M	824M	538M	596M	837M	602.6M

	Return On Equity	0.0808
	Return On Asset	0.0443
	Profit Margin	0.1 %
	Operating Margin	0.14 %
	Current Valuation	31.91 B
	Shares Outstanding	242.94 M
	Shares Owned By Insiders	0.64 %
	Shares Owned By Institutions	93.91 %
	Number Of Shares Shorted	2.3 M
	Price To Earning	64.49 X
	Price To Book	2.91 X
	Price To Sales	3.66 X
	Revenue	7.36 B
	Gross Profit	2.09 B
	EBITDA	1.15 B
	Net Income	609 M
	Cash And Equivalents	944 M
	Cash Per Share	6.58 X
	Total Debt	2.39 B
	Debt To Equity	0.75 %
	Current Ratio	1.65 X
	Book Value Per Share	43.59 X
	Cash Flow From Operations	837 M
	Short Ratio	1.73 X
	Earnings Per Share	3.49 X
	Price To Earnings To Growth	2.38 X
	Target Price	147.95
	Number Of Employees	23 K
	Beta	1.05
	Market Capitalization	30.79 B
	Total Asset	16.11 B
	Retained Earnings	2.6 B
	Working Capital	1.68 B
	Current Asset	2 B
	Current Liabilities	823 M
	Annual Yield	0.01 %
	Five Year Return	1.15 %
	Net Asset	16.11 B
	Last Dividend Paid	1.41

Xylem Inc Stock Probability Of Bankruptcy

Xylem Inc Company odds of financial distress Analysis

Probability Of Bankruptcy

Normalized

Z-Score

Current Xylem Probability Of Bankruptcy

Xylem Probability Of Bankruptcy Driver Correlations

Xylem Probability Of Bankruptcy Peer Comparison

Xylem Main Bankruptcy Drivers

Xylem ESG Sustainability

Xylem Fundamentals

About Xylem Fundamental Analysis

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY